University of California San Francisco
Give to UCSF
UCSF, a world-renowned center for the treatment of movement disorders, is holding an event to celebrate the program’s recognition by the Bachmann-Strauss Foundation as one of three new Centers of Excellence in the field.
A UCSF graduate program in complex biology led by Joseph DeRisi, PhD, is being lauded for its creativity with a $100,000 gift.
Eleven leading scientists from the California Institute for Quantitative Biosciences (QB3) presented their latest aging research findings and anti-aging strategies at a daylong symposium called “The Science of Staying Younger Longer.”
Barbara Drew is leading research to solve the dangerous problem of alarm fatigue, in which clinicians turn down, turn off or tune out the alarms because they're exhausted by their frequency and false readings.
New research by scientists at UC San Francisco shows that one of the brain’s fundamental self-protection mechanisms depends on coordinated, finely calibrated teamwork among neurons and non-neural cells.
In recent years, studies have reported inconsistent findings regarding whether calcium supplements used to prevent fractures increase the risk of heart attack.
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.
A UCSF opthamologist and bioengineer are collaborating to develop a tiny, flexible, implantable film that's able to deliver conventional medicines and also complex antibody-based drugs to treat eye diseases.
A team of UCSF researchers developing cell-based therapies for acute respiratory distress syndrome benefited from advisors who helped identify gaps in their development plan.
Ruben Rathnasingham, PhD, associate director of Early Translational Research at UCSF's Clinical and Translational Science Institute, is leading the team responsible for LaunchPad. In this Q&A, he discusses the project and how it can benefit researchers.
Teams of scientists at UCSF are collaborating to build upon existing imaging techniques and find new ways to monitor diseases using creative applications of emerging technologies.
The way cells divide to form new cells – to support growth, to repair damaged tissues, or simply to maintain our healthy adult functioning – is controlled in previously unsuspected ways, UCSF researchers have discovered.
Childbirth is not a major contributor to sexual dysfunction in women later in life, according to a new study led by UCSF researchers.
An individual’s race or ethnic background could be a determining factor when it comes to risk of atrial fibrillation, the most frequently diagnosed type of irregular heart rhythm, according to researchers at UCSF.
Often deadly “triple-negative” breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, UCSF reports.
Scientific progress and innovation are speeding along, faster than ever before, but arbitrary spending cuts are posing an unprecedented threat.
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
A consortium of the five University of California medical campuses, including UCSF, has been awarded a $12 million grant and designated by the National Institutes of Health as one of three Centers for Accelerated Innovations by the National Heart, Lung and Blood Institute.
The report earlier this year of a new hepatitis virus was a false alarm, according to UCSF researchers who correctly identified the virus as a contaminant present in a type of glassware used in many research labs.
A class of flame retardants that has been linked to learning difficulties in children has rapidly declined in pregnant women’s blood since the chemicals were banned in California a decade ago, according to a study led by researchers at UCSF.
Sally Rockey, deputy director for Extramural Research at the National Institutes of Health, is giving a talk titled “NIH: Interesting Times, Challenging Times” at UCSF on Tuesday, Sept. 24.
UCSF will receive a five year, $20 million grant as part of a first-of-its-kind tobacco science regulatory program by the U.S. Food and Drug Administration and the National Institutes of Health.
A small pilot study shows for the first time that changes in diet, exercise, stress management and social support may result in longer telomeres, the parts of chromosomes that affect aging.
A new link between meal times and daily changes in the immune system has been identified by UCSF researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy.
Scientists from UCSF have identified a new way to manipulate the immune system that may keep it from attacking the body’s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.
A new study found that use of blood levels of cystatin C to estimate kidney function strengthens the association between kidney function and risks of death and end-stage renal disease.
A protein at the center of Parkinson’s disease research now also has been found to play a key role in causing the destruction of bacteria that cause tuberculosis.
Scientists at UCSF are reporting that they have found a way to reverse some of the negative effects of aging on the brain, using a video game designed to improve cognitive control.
UCSF has launched Surplus Share, a new and exclusive online trading system that connects UC departments with each other to trade, sell or give away equipment, furniture and other supplies.